{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017873","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2025-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.419210+00:00","generated_at":"2026-05-18T09:30:40.756250+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tevogen Bio enters $50M at-the-market equity sales agreement with A.G.P.","bullets":["Sales agreement allows issuance and sale of up to $50M of common stock from time to time.","Sales will be made through A.G.P./Alliance Global Partners as agent at market prices.","Offering conducted under effective shelf registration statement (File No. 333-288218).","Company pays agent a commission on gross proceeds and provides customary indemnification.","Company is not obligated to sell any shares and may terminate the agreement at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017873","json":"https://secwatch.observer/filing/0001641172-25-017873.json","markdown":"https://secwatch.observer/filing/0001641172-25-017873.md","text":"https://secwatch.observer/filing/0001641172-25-017873.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000164117225017873/0001641172-25-017873-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000164117225017873/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:30:40.756250+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}